His main research concerns Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin. In his study, Weight loss is strongly linked to Surgery, which falls under the umbrella field of Internal medicine. His Endocrinology study integrates concerns from other disciplines, such as Strength training and Senescence.
His research investigates the connection between Diabetes mellitus and topics such as Randomized controlled trial that intersect with problems in Gerontology, Disease, Clinical trial, Hypoglycemia and Insulin glargine. Richard E. Pratley mostly deals with Liraglutide in his studies of Type 2 diabetes. His Insulin research is multidisciplinary, relying on both Rate ratio, Bedtime and Intensive care medicine.
Richard E. Pratley mostly deals with Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Insulin. When carried out as part of a general Internal medicine research project, his work on Weight loss is frequently linked to work in In patient, therefore connecting diverse disciplines of study. Endocrinology is represented through his Insulin resistance, Obesity, Glucose tolerance test, Adipose tissue and Leptin research.
His work deals with themes such as Metformin, Pharmacology and Intensive care medicine, which intersect with Type 2 diabetes. His Diabetes mellitus research is multidisciplinary, incorporating perspectives in Tolerability, Randomized controlled trial and Clinical trial. Insulin is often connected to Pima indians in his work.
His primary scientific interests are in Internal medicine, Type 2 diabetes, Semaglutide, Type 1 diabetes and Liraglutide. His Internal medicine research integrates issues from Basal insulin and Endocrinology. His Endocrinology study often links to related topics such as Meal.
The various areas that Richard E. Pratley examines in his Type 2 diabetes study include Severe hypoglycemia, Clinical trial, Disease and Intensive care medicine. His Liraglutide research also works with subjects such as
The scientist’s investigation covers issues in Internal medicine, Type 2 diabetes, Liraglutide, Semaglutide and Type 1 diabetes. His work on Glycemic, Baseline characteristics and Cardiovascular outcomes as part of general Internal medicine study is frequently linked to Ertugliflozin and Event, bridging the gap between disciplines. His study looks at the intersection of Type 2 diabetes and topics like Randomized controlled trial with Weight loss, Dulaglutide, Clinical trial and Cohort.
His Liraglutide study deals with the bigger picture of Endocrinology. As part of his studies on Endocrinology, Richard E. Pratley often connects relevant subjects like Post hoc. His work investigates the relationship between Insulin and topics such as Standard care that intersect with problems in Severe hypoglycemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.
Christian Weyer;Tohru Funahashi;Sachiyo Tanaka;Kikuko Hotta.
The Journal of Clinical Endocrinology and Metabolism (2001)
Leptin levels in human and rodent : Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
M. Maffei;J. Halaas;E. Ravussin;R.E. Pratley.
Nature Medicine (1995)
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
Christian Weyer;Clifton Bogardus;David M. Mott;Richard E. Pratley.
Journal of Clinical Investigation (1999)
Impaired fasting glucose and impaired glucose tolerance: implications for care.
David M. Nathan;Mayer B. Davidson;Ralph A. DeFronzo;Robert J. Heine.
Diabetes Care (2007)
Diabetes in Older Adults
M. Sue Kirkman;Vanessa Jones Briscoe;Nathaniel Clark;Hermes Florez.
Diabetes Care (2012)
Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.
C. Weyer;J. E. Foley;C. Bogardus;P. A. Tataranni.
Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.
Barbora Vozarova;Christian Weyer;Kristin Hanson;P. Antonio Tataranni.
Obesity Research (2001)
High Alanine Aminotransferase Is Associated With Decreased Hepatic Insulin Sensitivity and Predicts the Development of Type 2 Diabetes
Barbora Vozarova;Norbert Stefan;Robert S. Lindsay;Aramesh Saremi.
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
Richard E Pratley;Michael Nauck;Timothy Bailey;Eduard Montanya.
The Lancet (2010)
Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography
P. A. Tataranni;J.-F. Gautier;Kewei Chen;A. Uecker.
Proceedings of the National Academy of Sciences of the United States of America (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: